Back to today’s briefing

Story perspectives

Trump Administration's Delays Threaten COVID Vaccine Innovation

4/30/2025

33 8

Summary

Story summary

Former FDA officials are alarmed by the Trump administration's possible hold-up of COVID-19 vaccine approvals, especially for Novavax. Dr. Marty Makary, the FDA Commissioner, insists on the necessity for new trials and data. Critics warn that this shift to stricter requirements could erode public trust and stifle vaccine innovation at a crucial time.

1 of 1

Story summary

Former FDA officials are alarmed by the Trump administration's possible hold-up of COVID-19 vaccine approvals, especially for Novavax. Dr. Marty Makary, the FDA Commissioner, insists on the necessity for new trials and data. Critics warn that this shift to stricter requirements could erode public trust and stifle vaccine innovation at a crucial time.